Tolley EE, Zangeneh SZ, Chau G, Eron J, Grinsztejn B, Dawood H, Liu A, Magnus M, Hosseinipour M, Panchia R Li S, Cottle L, Rinehart A, Margolis D, McCauley M, Landovitz RJ. HIV R4P, Madrid, Spain, 2018. Oral presentation on “Future demand for an injectable PrEP: Acceptability of long-acting injectable cabotegravir (CAB LA) in HIV-uninfected Individuals in HPTN 077”.

Tolley EE, Li S, Atujuna M, Musara P, Justman J, Pathak S, Bekker LG, Farrior J, Sista N. International AIDS Society Meeting, Paris, France, 2017. Poster presentation on “Acceptability of rilpivirine LA (RPV LA): long-acting injectable pre-exposure prophylaxis (PrEP) in HPTN 076. (Ref: WEPEC0956)”.

Tolley EE, Zissette S, Palanee-Phillips T, Mathebula F, Siyanda T, Martinez A, Hartmann M, Montgomery E. International AIDS Society Meeting, Paris, France, 2017. Poster presentation on “Addressing issues impacting safe and consistent use of an HIV prevention intervention: Developing a Social Benefits-Harms Tool (SBHT)”.

Zissette S, Atujuna M, Tolley EE, Adimora A. International AIDS Society Meeting, Paris, France, June 23-26, 2017. Poster presentation on “HIV Prevention Trials Network-Women at Risk Committee: Cognitive testing of an instrument to evaluate acceptability and use of PrEP products among women”.

Bekker LG, Li S, Tolley EE, Marzinke M, Mgodi N, Justman J, Swaminathan S, Adeyeye A, Farrior J, Sista N. 2017 CROI Conference, Seattle, WA, USA, 2017. Poster presentation on “HPTN 076: TMC278 LA safe, tolerable and acceptable for HIV pre-exposure prophylaxis”.

Tolley EE, Guthrie KM, Zissette S, Louw CE, Kotze P, Gill K, Reddy K, Fava JL, MacQueen K. HIV Research 4 Prevention conference, Chicago, Illinois, 2016. Poster presentation on “Development and validation of measures to screen for potential adherence and support adherence prospectively”.

Tolley EE, Pack AP, Field S. Ryan E, Bockh E, Mackenzie C, Olawo A, Githuka G. HIV Research 4 Prevention conference, Cape Town, South Africa, 2014. Poster presentation on “Assessing the impact of message framing on microbicide acceptability”.

Tolley EE, Pack AP Field S. Ryan E, Bockh E, Mackenzie C, Olawo A, Githuka G. HIV Research 4 Prevention conference, Cape Town, South Africa, 2014. Poster presentation on “Risk disinhibition: The effect of microbicide communication materials on future prevention behavior (A-671-0005-00726)”.

Pack AP, Olawo A, Mackenzie C, Ryan E, Bockh E, Githuka G, Tolley EE. HIV Research 4 Prevention conference, Cape Town, South Africa, 2014. Poster presentation on “Microbicide counseling tools for health care providers: Promoting product acceptability and adherence (A-671-0025-00781)”.

Ryan E, Bockh E, Githuka G, Mackenzie C, Olawo A, Baker C, Tolley EE, Pack A. HIV Research 4 Prevention conference, Cape Town, South Africa, 2014. Poster presentation on “Engaging the community and stakeholders to develop microbicide communication materials in Kenya (A-671-0007-00375)”.

Tolley EE, Baumgartner JN, Field S, Headley J, Kaale A, Minja A, Kaaya S. HIV Research 4 Prevention conference, Cape Town, South Africa, 2014. Poster presentation on “Getting a foot in the door: Adolescent retention in a mock HIV prevention clinical trial (A-671-0024-00715)”.

Gamble T, Stanton J, Greene E, Taylor J, Pack AP; Shelus V, Tolley EE, Brown ST, El-Sadr W. HIV Research 4 Prevention conference, Cape Town, South Africa, 2014. Poster presentation on “Unanticipated impact of financial incentives on HIV patients and providers: Findings from a qualitative substudy (HPTN 065)”.

Greene E, Gamble T, Tolley EE, Pack A, Stanton J, Taylor J, Shelus V, Leider J, El-Sadr W, Branson B. HIV Research 4 Prevention conference, Cape Town, South Africa, 2014. Poster presentation on “The impact of implementing a financial incentive program for viral suppression on the clinic environment: Findings from a qualitative substudy of HPTN 065. (A-671-0005-00765)”.

Tolley EE, Morrow KM, Amico KR, MacQueen K. 9th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, USA, 2014 Poster presentation on “Development of a vaginal ring psychometric adherence scale for use in clinical trials (Abstract 394)”.

MacQueen K, Tolley EE, Owen DH, Amico KR, Morrow KM, Moench T. 9th International Conference on HIV Treatment and Prevention Adherence, Miami, FL, USA, 2014. Poster presentation on “Framework for a coherent, validated, and feasible adherence measurement and support package for use in ARV-based vaginal ring trials (Abstract 412)”.

Tolley EE, Friedland B, Gafos M, Amico KR, Van Damme L, Woodsong C, MacQueen K, Mansoor L, McCormack S. 4th Annual HIV & Women Meeting, Washington, DC., USA, 2014. Poster presentation on “Antiretroviral (ARV)-based prevention for women: A review of factors influencing choice, adherence and potential success of product formulations.”

Tolley EE, Ryan E, Pack AP, Bockh E, Mackenzie C, Githuka G, Sidibe S. 4th Annual HIV & Women Meeting, Washington, DC., USA, 2014. Poster presentation on “Communicating microbicides with women in mind: Developing materials that position microbicides for women in Kenya.”

Headley J, Tolley EE, Baumgartner JN, Kaaya S. 4th Annual HIV & Women Meeting, Washington, DC., USA, 2014. Oral presentation on “Adolescent and young women’s acceptability and use of a proxy microbicide gel or pill in a mock trial in Tanzania.”

Tolley EE. International Family Planning Conference, Addis Ababa, Ethiopia, 2013. Oral presentation on “Development of a longer-acting injectable contraceptive: Assessing acceptability and potential demand.”

Tolley EE. International Family Planning Conference, Addis Ababa, Ethiopia, 2013. Oral presentation on “Assessing acceptability of and adherence to multipurpose prevention technologies.”

Tolley EE. CONRAD Product Development Workshop 2013: HIV and Multipurpose Prevention Technologies, Washington, DC., USA, 2013. Oral presentation on “Assessing acceptability and adherence to multipurpose prevention methods.”

Tolley EE, Baumgartner JN, Kaaya S, Sastry J, Headley J. International Microbicides Conference in Sydney, Australia, 2012. Oral presentation on “Adolescent sexual risk and perceived need for PrEP: Paving the way for their future participation in HIV prevention trials.”

Baumgartner JN, Tolley EE, Kaaya S, Sastry J, Headley J. International Microbicides Conference in Sydney, Australia, 2012. Oral presentation on “Adolescent and community perspectives on microbicide trial participation in Tanzania and India”.

Tolley EE, Kaaya S, Kaale A, Kalungura H, Headley J, Baumgartner JN. XIX International AIDS Conference (IAS) in Washington, DC., USA, 2012. Poster presentation on “Do adolescents under 18 years old warrant inclusion in HIV prevention clinical research? Comparing sexual risk patterns of adolescent and young adult women in a mock trial in Tanzania.”

Tolley EE, Kaaya S, Bangapi D, Minja A, Headley J, Kaale A, Baumgartner JN. XIX International AIDS Conference (IAS) in Washington, D.C, USA, 2012. Poster presentation on “Feasibility of recruiting adolescent women into a mock HIV prevention trial”.

Baumgartner JN, Kaaya S, Kaale A, Headley J, Tolley EE. XIX International AIDS Conference (IAS) in Washington, DC., USA, 2012. Poster presentation on “Domestic violence among adolescents and young women in HIV prevention research in Tanzania: Participant experiences and measurement issues”.

Tolley EE. International Family Planning Conference, Dakar Senegal, 2011. Panel discussion on “Multipurpose prevention technology introduction – Planning for success”.

Evens E, Tolley EE, Headley J, McCarraher D, Hartmann M. International Family Planning Conference, Dakar, Senegal, 2011. Oral presentation on “Identifying factors that influence pregnancy intentions and contraceptive use”.

Tolley EE. Forum on Women and ARVS for Prevention, sponsored by FHI 360, Washington, DC, USA, 2011. Invited presentation on “Planning for PrEP with women in mind: Why targeting the ‘most-at-risk’ is likely to miss most women at risk”.

Tolley EE. Behavioral and Social Science Workshop sponsored by NIAID, Rockville, MD, USA, 2011. Invited presentation on “Application of theory in clinical trials to inform HIV risk measurement”.

Tolley EE, Weaver, Mark, Albert, Lisa. Microbicides 2010 Conference, Pittsburg, PA. USA, 2010. Poster presentation on “Refining recruitment in HIV prevention trials using DHS data”.

Tolley EE. Global Health Council’s 36th Annual International Conference, Washington, DC, USA, 2009. Invited presentation on “Married women & microbicide trials: Implications for product introduction.”

Tolley EE. Behavioral and Social Science in HIV Vaccine Clinical Research Workshop sponsored by NIAID, Washington, DC, USA, 2009. Invited presentation on “Predicting adherence within & beyond the clinical trial setting”.

Tolley EE. International HIV Treatment Adherence Conference, Miami, FL, USA, 2009. Invited panel presentation on “Adherence in microbicide clinical trials: Adherence matters.”

Tolley EE. Microbicides 2008 Conference, New Delhi, India, 2008. Oral presentation on "What predicts adherence in a safety trial – Is it generalizable beyond the trial setting?"

Tolley EE. Microbicides 2008 Conference, New Delhi, India, 2008. Oral presentation on “Feedback session on adherence and its measurement in microbicide clinical trials meeting sponsored by the Alliance for Microbicide Development and Family Health International”.

Wong CM, Johnson L, Patterson K, Batona G, Neema S, Johnson S, Hallad JS, Tolley EE, Van Damme L. Microbicides 2008 Conference, New Delhi, India, 2008. Poster presentation on “Acceptability of the cellulose sulfate vaginal microbicide among HIV-negative women in the Conrad phase III effectiveness trial.”

Hallad JS, Bhargava PK, Satyanarayan PBS, Van Damme L, Wong CM, Tolley EE. Microbicides 2008 Conference, New Delhi, India, 2008. Poster presentation on “Early closure of a phase III microbicide clinical trial in South India: Implications on trial participants and clinical staff”.

Tolley EE. Microbicides Trials Network 2007 Annual meeting in Washington, D.C, USA, 2007. Plenary presentation on “But will they use it? Examining microbicide use in the context of the HPTN 059 tenofovir gel safety trial”.

Tolley EE. Microbicides 2006 Conference, Cape Town, South Africa, 2006. Paper presented on “Ethical issues related to pregnancy during microbicide trials”.

Tolley EE. Microbicides 2006 Conference, Cape Town, South Africa, 2006. Paper presented on “Potential predictors of microbicide acceptability in India: Development and validation of measures”.

Tolley EE. Microbicides 2006 Conference, Cape Town, South Africa, 2006. Poster presentation on “Supporting the Trial: The use of behavioral and social science (BSS) methods for recruitment, retention, and monitoring community concerns”.

Tolley EE. Indian Council of Medical Research-Microbicide Development Project (ICMR-MDP) Workshop, New Delhi, India, 2005. Paper presentation on “Behavioral and social science research in support of phase III microbicide trials”.

Tolley EE. Meeting on Pregnancy in Microbicide Trials, Research Triangle Park, North Carolina, USA, 2005. Paper presentation on “Behavioral issues related to contraceptive use in microbicide clinical trials.”

Tolley EE, Severy L. 3rd South African Gender Based Violence and Health Conference, Stellenbosch, South Africa, 2005. Paper presentation on “Whatever happens is written in our fate: The relationship between marital violence, HIV risk and sexual power in Pune, India”.

Tolley EE. Expert witness for behavioral issues at Clinical Trials Working Group Meeting, sponsored by Alliance for Microbicides, London, England, 2005.

Tolley EE. Alliance for Microbicides Development Mini-Summit on Behavioral Research, Washington, DC., USA, 2005. Paper presentation on "Microbicide acceptability: Measuring what lies beneath the surface”.

Tolley EE. Symposium on Microbicides and Their Potential for Prevention of Sexually Transmitted Infections and Pregnancy, Mumbai, India, 2004. Paper presentation on “An expanded framework for examining microbicide acceptability: Conceptual and methodological issues".

Tolley EE, DeVellis R, Severy L, Kohli R, Foshee V, Eng E, Mehendale S. Microbicide 2004 Conference in London, England, 2004. Poster presentation on "Microbicide acceptability: Development and validation of psychometric scales".

Tolley EE, Naré C. Regional workshop on the future of Norplant services in West Africa held in Lomé, Togo, 1998. Paper presentation on “Women’s experiences with Norplant removal in four clinics in Dakar”.

Tolley EE, Welfens-Ekra C, Hyjazi K. International Conference on Reproductive Health in Mumbai, India, 1998. Paper presentation on “Adolescent abortion in Guinea and Côte d’Ivoire: What perpetuates the problem?”

Tolley EE. NCIH Conference, Washington, D.C., 1994. Paper presentation on "Participatory research in Bombay, India: Concerns in health".